glp 1 agonists vs sglt2 inhibitors Complementary Yet Distinct Roles of GLP-1 Receptor and in Cardiovascular Risk Reduction Perioperative GLP-1/GIP & SGLT2 Inhibitors

Semaglutide GLP-1 is only available through prescription and must be incorporated into a medical weight management plan by a healthcare provider based on an individuals specific health needs and weight loss goals

has received contract grant funding from Acadia Pharmaceuticals, Lundbeck, Takeda and Axovant pharmaceutical companies, as well as honoraria from Lundbeck, Lilly, Otsuka and Orion pharmaceutical companies

Obesity is a wellestablished risk factor for AFib and is associated with poorer outcomes following catheter ablation

Exendin-4 induces cytotoxic autophagy in two ovarian cancer cell lines through inhibition of Mtorc1 mediated by activation of AMPK and suppression of akt

doi:10.1016/j.obpill.2022.100047